JCM
GILD icon

JD Capital Management’s Gilead Sciences GILD Stock Holding History

JD Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-79,906
Closed -$5.43M – 30
2017
Q1 		$5.43M Buy
+79,906
New +$5.62M 1.76% 15

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JD Capital Management's GILD Position: Q2 2017 in Review

JD Capital Management sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 79,906 shares — an estimated $5.43M sold.

JD Capital Management first reported a position in GILD in Q1 2017 and held it in 1 quarter. The position peaked at $5.43M in Q1 2017. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • JD Capital Management reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • JD Capital Management sold 79,906 Gilead Sciences shares in Q2 2017, an estimated $5.43M.
  • JD Capital Management first reported a position in Gilead Sciences in Q1 2017 and held it in 1 quarter.
  • JD Capital Management's Gilead Sciences position peaked at $5.43M in Q1 2017.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on JD Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.